CN1483469A - Baidianxiao treaditional Chinese medicine for treating vitiligo and preparation method thereof - Google Patents
Baidianxiao treaditional Chinese medicine for treating vitiligo and preparation method thereof Download PDFInfo
- Publication number
- CN1483469A CN1483469A CNA031502156A CN03150215A CN1483469A CN 1483469 A CN1483469 A CN 1483469A CN A031502156 A CNA031502156 A CN A031502156A CN 03150215 A CN03150215 A CN 03150215A CN 1483469 A CN1483469 A CN 1483469A
- Authority
- CN
- China
- Prior art keywords
- baidianxiao
- fructus
- chinese medicine
- herba
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 65
- 238000002360 preparation method Methods 0.000 title claims abstract description 28
- 206010047642 Vitiligo Diseases 0.000 title description 27
- 239000000706 filtrate Substances 0.000 claims abstract description 22
- 239000000203 mixture Substances 0.000 claims abstract description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 21
- 229910052957 realgar Inorganic materials 0.000 claims abstract description 21
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229910052717 sulfur Inorganic materials 0.000 claims abstract description 19
- 239000011593 sulfur Substances 0.000 claims abstract description 19
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 12
- 241001077909 Sigesbeckia Species 0.000 claims abstract description 7
- 239000002552 dosage form Substances 0.000 claims abstract description 7
- 238000000034 method Methods 0.000 claims abstract description 6
- 238000001914 filtration Methods 0.000 claims abstract description 4
- 206010024380 Leukoderma Diseases 0.000 claims description 20
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 claims description 12
- 239000004327 boric acid Substances 0.000 claims description 12
- 239000002994 raw material Substances 0.000 claims description 12
- 241000628997 Flos Species 0.000 claims description 11
- -1 Lithargyrum Inorganic materials 0.000 claims description 11
- 241000522620 Scorpio Species 0.000 claims description 11
- 239000009490 scorpio Substances 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000012467 final product Substances 0.000 claims description 6
- 229940079593 drug Drugs 0.000 claims description 5
- 239000002674 ointment Substances 0.000 claims description 4
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 4
- 239000007921 spray Substances 0.000 claims description 4
- 239000002966 varnish Substances 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 3
- NINIDFKCEFEMDL-LZFNBGRKSA-N sulfur-38 atom Chemical compound [38S] NINIDFKCEFEMDL-LZFNBGRKSA-N 0.000 claims description 3
- 238000002481 ethanol extraction Methods 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 238000003809 water extraction Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 11
- 230000001225 therapeutic effect Effects 0.000 abstract description 3
- 230000002500 effect on skin Effects 0.000 abstract description 2
- 239000000284 extract Substances 0.000 abstract description 2
- MUKYLHIZBOASDM-UHFFFAOYSA-N 2-[carbamimidoyl(methyl)amino]acetic acid 2,3,4,5,6-pentahydroxyhexanoic acid Chemical compound NC(=N)N(C)CC(O)=O.OCC(O)C(O)C(O)C(O)C(O)=O MUKYLHIZBOASDM-UHFFFAOYSA-N 0.000 abstract 1
- 241001446509 Psoralea Species 0.000 abstract 1
- 241000593775 Serissa Species 0.000 abstract 1
- 241000270295 Serpentes Species 0.000 abstract 1
- 241000819233 Tribulus <sea snail> Species 0.000 abstract 1
- 238000001816 cooling Methods 0.000 abstract 1
- 235000019441 ethanol Nutrition 0.000 abstract 1
- HTUMBQDCCIXGCV-UHFFFAOYSA-N lead oxide Chemical compound [O-2].[Pb+2] HTUMBQDCCIXGCV-UHFFFAOYSA-N 0.000 abstract 1
- YEXPOXQUZXUXJW-UHFFFAOYSA-N lead(II) oxide Inorganic materials [Pb]=O YEXPOXQUZXUXJW-UHFFFAOYSA-N 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000002156 mixing Methods 0.000 abstract 1
- 238000002791 soaking Methods 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 229940047183 tribulus Drugs 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 21
- 239000008280 blood Substances 0.000 description 16
- 210000004369 blood Anatomy 0.000 description 15
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 12
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 210000003734 kidney Anatomy 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 6
- 208000002474 Tinea Diseases 0.000 description 5
- 230000003203 everyday effect Effects 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 206010063409 Acarodermatitis Diseases 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 206010025421 Macule Diseases 0.000 description 4
- 241000447727 Scabies Species 0.000 description 4
- 241000130764 Tinea Species 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 208000005687 scabies Diseases 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 208000003251 Pruritus Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 244000045947 parasite Species 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010027145 Melanocytic naevus Diseases 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010005913 Body tinea Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- GUTLYIVDDKVIGB-OUBTZVSYSA-N Cobalt-60 Chemical compound [60Co] GUTLYIVDDKVIGB-OUBTZVSYSA-N 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- 206010057315 Daydreaming Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- 206010018092 Generalised oedema Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 241001313288 Labia Species 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 206010043189 Telangiectasia Diseases 0.000 description 1
- 208000007712 Tinea Versicolor Diseases 0.000 description 1
- 206010056131 Tinea versicolour Diseases 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 241000234314 Zingiber Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 208000024783 anasarca Diseases 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002061 histotrophic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 201000006451 norwegian scabies Diseases 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 208000017983 photosensitivity disease Diseases 0.000 description 1
- 231100000434 photosensitization Toxicity 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 208000009056 telangiectasis Diseases 0.000 description 1
- GMMAPXRGRVJYJY-UHFFFAOYSA-J tetrasodium 4-acetamido-5-hydroxy-6-[[7-sulfonato-4-[(4-sulfonatophenyl)diazenyl]naphthalen-1-yl]diazenyl]naphthalene-1,7-disulfonate Chemical compound [Na+].[Na+].[Na+].[Na+].OC1=C2C(NC(=O)C)=CC=C(S([O-])(=O)=O)C2=CC(S([O-])(=O)=O)=C1N=NC(C1=CC(=CC=C11)S([O-])(=O)=O)=CC=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 GMMAPXRGRVJYJY-UHFFFAOYSA-J 0.000 description 1
- 201000003875 tinea corporis Diseases 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 231100000925 very toxic Toxicity 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention relates to a Chinese medicine composition for curing leukodermia and its preparation method. It is made of 24 Chinese medicinal materials of serissa, siegesbeckia, tribulus fruit, psoralea seed, snake slough and others through the processes of mixing, extracting by adding ethyl alcohol, filtering extract, cooling filtrate, soaking by adding realgar, litharge and sulfur for 5-10 days, filtering and making the filtrate into various dosage forms according to conventional dermal external application medicine preparation method. Its therapeutic effect is obvious, and it has no toxic side effect.
Description
Technical field
The present invention relates to the dermopathic medicine of a kind of treatment, relate in particular to leukodermic medicine ' Baidianxiao ' for treating leukoderma Chinese medicine composition of a kind of treatment and preparation method thereof.
Background technology
Vitiligo is still one of the world's four big pertinacious diseases so far, and it is obstinate that the state of an illness that in recent years should disease also tends to, and is one of disease of World Health Organization (WHO) and skin research field primary study and control.This disease cause of disease is unclear fully as yet so far.It is generally acknowledged relevant with multiple factors such as heredity, infection, immunity, metabolism, endocrine, spirit.How vitiligo can not form melanin by skin and cause that symptom is to present blocks of white macula on the skin, and is superficial, also claims leukoderma.
At present, therapy for vitiligo is mainly based on medicine, though the method for treatment is many, can only reach recent clinical effectiveness mostly, and recurrence is difficult to suppress.Western medicine adopts 17-hydroxy-11-dehydrocorticosterone or cellular immunization inhibitor more, though this class medicine has short term effect preferably, but the disadvantage that they exist is epidermis and the corium attenuation that life-time service can make skin, and can cause serious toxicity such as telangiectasis and addiction, complication is many, subject range is little, and price is also relatively more expensive, is not the leukodermic direction of treatment; And the shortcoming that treatment by Chinese herbs exists uncertain therapeutic efficacy to cut.
Summary of the invention
The purpose of this invention is to provide the dermopathic medicine of a kind of treatment, leukodermic medicine ' Baidianxiao ' for treating leukoderma Chinese medicine composition of a kind of treatment and preparation method thereof especially is provided, it is serious to have overcome present western medicine toxicity, the shortcoming that treatment by Chinese herbs exists uncertain therapeutic efficacy to cut.
The objective of the invention is to be achieved through the following technical solutions:
A kind of medicine ' Baidianxiao ' for treating leukoderma Chinese medicine composition comprises following component: Radix Serissae, Herba Siegesbeckiae, Fructus Atriplicis Sibiricae, Fructus Psoraleae, Periostracum Serpentis, Sal, Herba Portulacae, Sucus Zingberis, the Fructus Solani melongenae base of a fruit, Scorpio, Fructus Mume, Herba Macleayae Cordatae, white Serpentis, Nidus Vespae, the Radix Angelicae Dahuricae, Radix Angelicae Sinensis, boric acid, Flos Carthami, Herba Ecliptae, Fructus Lycii, Radix Polygoni Multiflori, Realgar, Lithargyrum, sulfur;
Described component can be following parts by weight of component: Radix Serissae 15-20 Herba Siegesbeckiae 10-15, Fructus Atriplicis Sibiricae 15-25, Fructus Psoraleae 20-30, Periostracum Serpentis 10-15, Sal 30-50, Herba Portulacae 15-30, Sucus Zingberis 25-30, Fructus Solani melongenae base of a fruit 30-40, Scorpio 10-15, Fructus Mume 30-35, Herba Macleayae Cordatae 20-25, white Serpentis 20-25, Nidus Vespae 10-15, Radix Angelicae Dahuricae 20-30, Radix Angelicae Sinensis 15-20, boric acid 30-35, Flos Carthami 20-25, Herba Ecliptae 15-20, Fructus Lycii 20-25, Radix Polygoni Multiflori 15-20, Realgar 50-60, Lithargyrum 40-45, sulfur 30-45;
Described component is preferably following parts by weight of component: Radix Serissae 18, Herba Siegesbeckiaes 12, Fructus Atriplicis Sibiricae 20, Fructus Psoraleae 25, Periostracum Serpentis 12, Sal 40, Herba Portulacae 22, Sucus Zingberis 28, the Fructus Solani melongenae base of a fruit 35, Scorpio 12, Fructus Mume 32, Herba Macleayae Cordatae 22, white Serpentis 22, Nidus Vespae 12, the Radix Angelicae Dahuricae 25, Radix Angelicae Sinensis 18, boric acid 32, Flos Carthami 22, Herba Ecliptae 18, Fructus Lycii 22, Radix Polygoni Multiflori 18, Realgar 55, Lithargyrum 42, sulfur 38;
Described medicine ' Baidianxiao ' for treating leukoderma Chinese medicine composition can be made into said external preparation for skin dosage form on any pharmaceutics, especially is water preparation, varnish, unguentum, spray.
The preparation method of a kind of medicine ' Baidianxiao ' for treating leukoderma Chinese medicine composition of the present invention may further comprise the steps:
Get the above-mentioned raw materials medicine, mix, add ethanol or water extraction, extracting liquid filtering adds Realgar, Lithargyrum, sulfur and soaked 5-10 days, filters, get filtrate routinely external preparation for skin pharmaceutical preparation method make various dosage forms promptly.
Described method also comprises: after getting the above-mentioned raw materials medicine and concocting respectively, mix, or be ground into corase meal altogether, put into container such as marmite, vial, and to add concentration be the ethanol of 45-80% that preferably concentration is that 80% soak with ethanol raw material gets final product; Slow fire boils 2 times-3 times, filters, and gets filtrate; Filtrate is put cold, and adding Realgar, Lithargyrum, sulfur soaked 5-10 days, especially were 7 days; Soak filters, and gets filtrate, makes various dosage forms in external preparation for skin pharmaceutical preparation method routinely, and fill promptly gets described medicine ' Baidianxiao ' for treating leukoderma Chinese medicine composition.
Using method: impose on the vitiligo affected part, every day 3-4 time, two months is a course of treatment, and can cure general 2-3 course of treatment; Preferably every day with ginger slice wiping vitiligo affected part to little red after, the reuse Rhizoma Zingiberis Recens is stained with medicine juice and is put affected part on the skin, every day 3-4 time, two months is a course of treatment, can cure general 2-3 course of treatment, discrete patient 4-5 the healing course of treatment, suitable various vitiligo.
Ingredient effect of the present invention:
Radix Serissae, bitter, hot, cool, cold in nature, nontoxic, have and dispel the wind, heat clearing away, the effect of detoxifcation.
Herba Siegesbeckiae, is gone into the Liver and kidney warp, settling five organs, hair growth promoting, hair color, nourishing YIN and benefiting blood, the tonify deficiency of clothes, but curing vitiligo at bitter, cold, little suffering.
Fructus Atriplicis Sibiricae, bitter, hot, warm in nature, go into liver lung stomach warp, the wind therapeutic method to keep the adverse QI flowing downwards promoting the circulation of blood of loosing, the speckle that goes out, but curing vitiligo.
Fructus Psoraleae, bitter, hot, warm in nature, return the kidney spleen channel, the external curing vitiligo contains Fructus Psoraleae and different benefit fat element, can promote the newborn of dermal melanin and cause photosensitization, can expand local vascular, improves histotrophic nutrition.
Periostracum Serpentis contains osseocolla essence etc., and the Periostracum Serpentis extract that boils has antiinflammatory action, can suppress leukocytic hypertrophy and the permeability of blood vessel is provided, but curing vitiligo.
Sal relieves inflammation or internal heat, removing heat from blood, detoxifcation, controls pathogen, mends skin raw meat, blood circulation promoting and blood stasis dispelling, removing heat from blood and moisturizes.Dispel the wind, kill fire, polyphagia can make colour of skin brilliant black, and vitiligo mostly is disharmony between QI and blood, or the Liver and kidney asthenia of essence and blood, or multiple paathogenic factor such as stagnation of blood stasis wind-engaging causes imbalance of YIN and YANG, causes that local melanin disappears, Sal can make blood vessels condense and variable color, can urge Intradermal melanin and generate, so but curing vitiligo.
Herba Portulacae, hot, cold, little acid, heat-clearing and toxic substances removing, QI invigorating, removing food stagnancy stagnates, and kills fire, and cooperate curing vitiligo to imitate with boric acid excellent.
Realgar, the detoxifcation parasite killing goes dampness, dispels the wind.
Sucus Zingberis promotes skin venation microcirculation, promotes the absorption of medicine to affected part.
The Fructus Solani melongenae base of a fruit contains a large amount of ferrous components, promotes the affected part metabolism, but curing vitiligo.
Scorpio, suffering, poisonous, go into Liver Channel, meridian passage dredging detoxication is controlled tinea corporis, fish scale.
Fructus Mume, sour in the mouth, temperature, flat, nontoxic, control dead flesh, melanotic nevus, to go into dead flesh, dislike meat, melanotic nevus then removes, incarnation is controlled psoriasis, children's's tinea alba disease such as do not heal for many years, but the external curing vitiligo.
Sulfur, topical application has the cutin of clearing up to skin, the effect of softening skin, pain relieving, infection, the protection wound surface promotes healing, to scrotum, labia, pruritus due to damp pathogen, scabies, malignant boil, bald, and cuts dried exudative dermatitis etc. and curing vitiligo.
Herba Macleayae Cordatae, bitter, hot, warm in nature, very toxic, detumescence, detoxifcation, parasite killing can be made last the accent and be coated with curing vitiligo.
White Serpentis, Serpentis property is walked to scurry, and also benefaction nowhere less than, so can draw the fresh breeze medicine, reach also from internal organs to sick institute, what solid wind was given birth to prolongs, and makes its power obtaining recovery from illness invariably, and Serpentis is the special medicine of vitiligo specially except that the wind of the bottom of heart in vain.
Nidus Vespae, sweet, put down, return the stomach warp, have merit poisoning worm, wind-expelling pain-stopping, and can treat carbuncle, scrofula, the effect of tinea skin ulcer.
The Radix Angelicae Dahuricae can go the dried defect tinea of dough cover, and the wind of the skin migration of dispelling is treated wind, controls skin Pruritus such as welt, decortication, wet dry, sepage, can control scabies, longue skin etc.
Radix Angelicae Sinensis, Gan Xin, temperature, nontoxic, be the promoting the circulation of blood medicine of enriching blood.
Boric acid can be transferred pH value in this medicine, make it stored for a long time.
Flos Carthami is invigorated blood circulation, blood stasis removing, and color has been made us in pain relieving.
Herba Ecliptae, removing heat from blood, hemostasis, black beard and hair, kidney tonifying the moon can be taken a tonic or nourishing food to build up one's health melanin, thus but curing vitiligo.
Fructus Lycii is gone into the Autoscreen II lung meridian, the nourishing kidney lung moistening, and tonifying liver makes eye bright, and makes longue meat, beneficial color.
Radix Polygoni Multiflori is made ripe the kidney invigorating, benefiting essence-blood, and black beard and hair, controlling nocturnal emission with astringent drugs gas, beneficial vim and vigour, black hair on the temple, improving healthy complexion is controlled the skin ulcer scabies, stubborn dermatitis, red vitiligo.
The Lithargyrum as medicine for external use, can reduce inflammation, and has convergence anticorrosion, detumescence poison, and scar is done on the face that goes out, to remove tinea versicolor external curing vitiligo effective.
Stone sulfur is ground into powder, and is hot flat, poisonous, scorching, and scabies is controlled in the parasite killing detoxifcation, bald, crusted scabies, and itching over the body, the dead flesh of skin that looses, absentminded evil thought is controlled tinea.
The present invention has the following advantages:
1, medicine-feeding is closed and is gathered, and can dispel the wind, detoxifies, invigorates blood circulation, removing heat from blood, has nourishing the liver and kidney, benefiting QI and nourishing blood, and removing heat from blood, the granulation promoting skin moistening is taken a tonic or nourishing food to build up one's health melanin, has made us color, the many types of vitiligo of treatment of can dispeling the wind.
2, short treating period, instant effect has no side effect.
3, need not other medicines cooperate, direct wiping white macula position, if every day with Rhizoma Zingiberis Recens erasing vitiligo affected part to little red after, the reuse Rhizoma Zingiberis Recens is stained with medicine juice and is put affected part on the skin, more remarkable treatment effect.
The insane syndrome caused by wind pathogen disease of medicine dialogue of the present invention clinical case efficacy analysis
From year June in October, 2002 to 2003, treat vitiligo 250 examples altogether in Linquan County, Anhui hospital dermatology department out-patient department, wherein male 145 examples, women 105 examples.
Using method: medicine is embodiment 1 varnish, and cleaning skin is embrocated this medicine on the surface, affected part, and every day 3 times, 7 days is a course of treatment.
Curative effect judging standard: 1. clinical cure: skin color recovers normal, and no vestige is as excellent as before, glossy as jade; 2. produce effects: white macula obviously disappears, and transfers brown white to by pure white, gradually to normal skin; 3. take a turn for the better: white macula gradually transfers erythema to, and foxiness occurs; 4. invalid: medication does not have significant change after 2 months; 5. recurrence: follow the trail of after 3 years and pay a return visit.Observation shows that only 3 patients have slight anasarca, and 1-2 disappears after week or after the drug withdrawal, does not influence treatment.
Table 5 Drug therapy vitiligo of the present invention disease efficacy analysis
The produce effects of the curing name of disease example number invalid effective percentage recurrence relapse rate that takes a turn for the better
(%) (people) (%) for (people) (people) (people) (people) (people)
Vitiligo 250 175 64 11 0 100 21 12
The specific embodiment
Embodiment 1
Water preparation
Take by weighing each component (kg) by following proportioning: Radix Serissae 18, Herba Siegesbeckiaes 12, Fructus Atriplicis Sibiricae 20, Fructus Psoraleae 25, Periostracum Serpentis 12, Sal 40, Herba Portulacae 22, Sucus Zingberis 28, the Fructus Solani melongenae base of a fruit 35, Scorpio 12, Fructus Mume 32, Herba Macleayae Cordatae 22, white Serpentis 22, Nidus Vespae 12, the Radix Angelicae Dahuricae 25, Radix Angelicae Sinensis 18, boric acid 32, Flos Carthami 22, Herba Ecliptae 18, Fructus Lycii 22, Radix Polygoni Multiflori 18, Realgar 55, Lithargyrum 42, sulfur 38.
Preparation method may further comprise the steps: get above-mentioned raw materials, be mixed in proportion, be ground into corase meal, cross 10 mesh sieves, put into marmite, and to add concentration be that 50% soak with ethanol raw material gets final product; Slow fire boils twice, filters, and gets filtrate; Filtrate is put cold, and adding Realgar, Lithargyrum, sulfur soaked 7 days; Soak filters, and gets filtrate, and it is 100L that the adjustment water content makes solution, fill, and 100 ℃ of steam sterilizations promptly got water preparation in 20 minutes.
Embodiment 2
Varnish
Take by weighing each component (kg) by following proportioning: Radix Serissae 20, Herba Siegesbeckiaes 15, Fructus Atriplicis Sibiricae 25, Fructus Psoraleae 30, Periostracum Serpentis 15, Sal 50, Herba Portulacae 30, Sucus Zingberis 30, the Fructus Solani melongenae base of a fruit 40, Scorpio 15, Fructus Mume 35, Herba Macleayae Cordatae 25, white Serpentis 25, Nidus Vespae 15, the Radix Angelicae Dahuricae 30, Radix Angelicae Sinensis 20, boric acid 35, Flos Carthami 25, Herba Ecliptae 20, Fructus Lycii 25, Radix Polygoni Multiflori 20, Realgar 60, Lithargyrum 45, sulfur 45g.
Preparation method may further comprise the steps: get above-mentioned raw materials, be mixed in proportion, be ground into corase meal, cross 10 mesh sieves, put into marmite, and to add concentration be that 80% soak with ethanol raw material gets final product; Slow fire boils 3 times, filters, and gets filtrate; Filtrate is put cold, and adding Realgar, Lithargyrum, sulfur soaked 10 days; Soak filters, and gets filtrate, concentrates, and adjusting water content is 20%, fill, and 1000,10g/ props up, and cobalt 60 is sterilized 15 minutes promptly.
Embodiment 3
Unguentum
Take by weighing each component (kg) by following proportioning: Radix Serissae 15, Herba Siegesbeckiaes 10, Fructus Atriplicis Sibiricae 15, Fructus Psoraleae 20, Periostracum Serpentis 10, Sal 30, Herba Portulacae 15, Sucus Zingberis 25, Fructus Solani melongenae base of a fruit 30-40, Scorpio 10, Fructus Mume 30, Herba Macleayae Cordatae 20, white Serpentis 20, Nidus Vespae 10, the Radix Angelicae Dahuricae 20, Radix Angelicae Sinensis 15, boric acid 30, Flos Carthami 20, Herba Ecliptae 15, Fructus Lycii 20, Radix Polygoni Multiflori 15, Realgar 50, Lithargyrum 40, sulfur 30.
Preparation method may further comprise the steps: get above-mentioned raw materials, be mixed in proportion, be ground into coarse powder, put into marmite, and to add concentration be that 45% soak with ethanol raw material gets final product; Slow fire boils 3 times, filters, and gets filtrate; Filtrate is put cold, and adding Realgar, Lithargyrum, sulfur soaked 5 days; Soak filters, and gets filtrate, concentrates to be thick shape, add excipient octadecanol 4 grams, stearic acid 10 grams, glyceryl monostearate 5 grams, vaseline 6 grams, glycerol 10 grams, triethanolamine 0.8 gram and surplus distilled water are mixed with unguentum, fill, 10g/ props up, and 100 ℃ of steam sterilizations 15 minutes promptly.
Embodiment 4
Spray
Take by weighing each component (kg) by following proportioning: Radix Serissae 16, Herba Siegesbeckiaes 11, Fructus Atriplicis Sibiricae 22, Fructus Psoraleae 26, Periostracum Serpentis 13, Sal 437, Herba Portulacae 21, Sucus Zingberis 26, the Fructus Solani melongenae base of a fruit 32, Scorpio 13, Fructus Mume 30, Herba Macleayae Cordatae 21, white Serpentis 23, Nidus Vespae 13, the Radix Angelicae Dahuricae 24, Radix Angelicae Sinensis 17, boric acid 30, Flos Carthami 23, Herba Ecliptae 19, Fructus Lycii 21, Radix Polygoni Multiflori 19, Realgar 54, Lithargyrum 41, sulfur 39.
Preparation method may further comprise the steps: get above-mentioned raw materials, be mixed in proportion, put into container, and to add concentration be that 50% soak with ethanol raw material gets final product; Slow fire boils twice, filters, and gets filtrate; Filtrate is put cold, and adding Realgar, Lithargyrum, sulfur soaked 10 days; Soak filters, and gets filtrate, and adjusting water content, to make solution be 1000L, the fill spray bottle, and the 50ml/ bottle, 100 ℃ of steam sterilizations 30 minutes, promptly.
Claims (8)
1, a kind of medicine ' Baidianxiao ' for treating leukoderma Chinese medicine composition comprises following component: Radix Serissae, Herba Siegesbeckiae, Fructus Atriplicis Sibiricae, Fructus Psoraleae, Periostracum Serpentis, Sal, Herba Portulacae, Sucus Zingberis, the Fructus Solani melongenae base of a fruit, Scorpio, Fructus Mume, Herba Macleayae Cordatae, white Serpentis, Nidus Vespae, the Radix Angelicae Dahuricae, Radix Angelicae Sinensis, boric acid, Flos Carthami, Herba Ecliptae, Fructus Lycii, Radix Polygoni Multiflori, Realgar, Lithargyrum, sulfur.
2, medicine ' Baidianxiao ' for treating leukoderma Chinese medicine composition according to claim 1, described component can be following parts by weight of component: Radix Serissae 15-20 Herba Siegesbeckiae 10-15, Fructus Atriplicis Sibiricae 15-25, Fructus Psoraleae 20-30, Periostracum Serpentis 10-15, Sal 30-50, Herba Portulacae 15-30, Sucus Zingberis 25-30, Fructus Solani melongenae base of a fruit 30-40, Scorpio 10-15, Fructus Mume 30-35, Herba Macleayae Cordatae 20-25, white Serpentis 20 25, Nidus Vespae 10-15, Radix Angelicae Dahuricae 20-30, Radix Angelicae Sinensis 15-20, boric acid 30-35, Flos Carthami 20-25, Herba Ecliptae 15-20, Fructus Lycii 20-25, Radix Polygoni Multiflori 15-20, Realgar 50-60, Lithargyrum 40-45, sulfur 30-45.
3, medicine ' Baidianxiao ' for treating leukoderma Chinese medicine composition according to claim 1, described component is following parts by weight of component: Radix Serissae 18, Herba Siegesbeckiaes 12, Fructus Atriplicis Sibiricae 20, Fructus Psoraleae 25, Periostracum Serpentis 12, Sal 40, Herba Portulacae 22, Sucus Zingberis 28, the Fructus Solani melongenae base of a fruit 35, Scorpio 12, Fructus Mume 32, Herba Macleayae Cordatae 22, white Serpentis 22, Nidus Vespae 12, the Radix Angelicae Dahuricae 25, Radix Angelicae Sinensis 18, boric acid 32, Flos Carthami 22, Herba Ecliptae 18, Fructus Lycii 22, Radix Polygoni Multiflori 18, Realgar 55, Lithargyrum 42, sulfur 38.
4, medicine ' Baidianxiao ' for treating leukoderma Chinese medicine composition according to claim 1, described medicine ' Baidianxiao ' for treating leukoderma Chinese medicine composition are said external preparation for skin dosage form on any pharmaceutics.
5, medicine ' Baidianxiao ' for treating leukoderma Chinese medicine composition according to claim 1, described medicine ' Baidianxiao ' for treating leukoderma Chinese medicine composition is water preparation, varnish, unguentum, spray.
6, a kind of preparation method of medicine ' Baidianxiao ' for treating leukoderma Chinese medicine composition may further comprise the steps:
The weighting profit requires the 1-3 crude drug, mixes, and adds ethanol or water extraction, extracting liquid filtering, adding Realgar, Lithargyrum, sulfur soaked 5-10 days, filtered, get filtrate routinely external preparation for skin pharmaceutical preparation method make various dosage forms, promptly get described medicine ' Baidianxiao ' for treating leukoderma Chinese medicine composition.
7, the preparation method of medicine ' Baidianxiao ' for treating leukoderma Chinese medicine composition according to claim 6, described method also comprises: the weighting profit requires the 1-3 crude drug to be ground into coarse powder altogether, puts into container, and adding concentration is that the soak with ethanol raw material of 45-80% gets final product; Slow fire boils 2 times-3 times, filters, and gets filtrate; Filtrate is put cold, and adding Realgar, Lithargyrum, sulfur soaked 5-10 days; Soak filters, and gets filtrate, and external preparation for skin pharmaceutical preparation method is made various dosage forms routinely, promptly gets described medicine ' Baidianxiao ' for treating leukoderma Chinese medicine composition.
8, the preparation method of medicine ' Baidianxiao ' for treating leukoderma Chinese medicine composition according to claim 7, described concentration of alcohol are 80%; It is 7 days that described adding Realgar, Lithargyrum, sulfur soak.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB031502156A CN100350934C (en) | 2003-07-21 | 2003-07-21 | Baidianxiao treaditional Chinese medicine for treating vitiligo and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB031502156A CN100350934C (en) | 2003-07-21 | 2003-07-21 | Baidianxiao treaditional Chinese medicine for treating vitiligo and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1483469A true CN1483469A (en) | 2004-03-24 |
| CN100350934C CN100350934C (en) | 2007-11-28 |
Family
ID=34156453
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB031502156A Expired - Fee Related CN100350934C (en) | 2003-07-21 | 2003-07-21 | Baidianxiao treaditional Chinese medicine for treating vitiligo and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100350934C (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100450524C (en) * | 2005-12-21 | 2009-01-14 | 李德峰 | Chinese medicine composition for treating facial skin disease and its preparing method |
| CN101204410B (en) * | 2007-12-19 | 2011-09-21 | 干慕美 | External medicine for vitligo |
| CN103505574A (en) * | 2013-06-28 | 2014-01-15 | 保定华仁白癜风医院 | Traditional Chinese medicine ointment used for treating leucoderma, and preparation method thereof |
| CN104491170A (en) * | 2014-11-23 | 2015-04-08 | 溧阳市天目湖大紫王葡萄专业合作社 | Traditional Chinese medicinal composition for treating pathogenic wind type leucoderma |
| CN106215122A (en) * | 2016-08-31 | 2016-12-14 | 亳州市庆聚药业销售有限公司 | Traditional Chinese medicine formula for treating leucoderma |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1202375A (en) * | 1998-06-29 | 1998-12-23 | 叶庆莲 | Chinese drug for curing vitiligo |
| CN1127348C (en) * | 2001-07-17 | 2003-11-12 | 张仲武 | Leukoderma treating medicine |
| CN1337266A (en) * | 2001-09-24 | 2002-02-27 | 杨国帅 | Leukoderma liniment |
-
2003
- 2003-07-21 CN CNB031502156A patent/CN100350934C/en not_active Expired - Fee Related
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100450524C (en) * | 2005-12-21 | 2009-01-14 | 李德峰 | Chinese medicine composition for treating facial skin disease and its preparing method |
| CN101204410B (en) * | 2007-12-19 | 2011-09-21 | 干慕美 | External medicine for vitligo |
| CN103505574A (en) * | 2013-06-28 | 2014-01-15 | 保定华仁白癜风医院 | Traditional Chinese medicine ointment used for treating leucoderma, and preparation method thereof |
| CN104491170A (en) * | 2014-11-23 | 2015-04-08 | 溧阳市天目湖大紫王葡萄专业合作社 | Traditional Chinese medicinal composition for treating pathogenic wind type leucoderma |
| CN106215122A (en) * | 2016-08-31 | 2016-12-14 | 亳州市庆聚药业销售有限公司 | Traditional Chinese medicine formula for treating leucoderma |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100350934C (en) | 2007-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103520578B (en) | A kind of Chinese medicine composition for the treatment of oral ulcer and preparation method thereof | |
| CN101181559B (en) | Preparation method of traditional Chinese medicine preparation for treating fungal skin diseases | |
| CN103768567B (en) | A kind of black plaster and preparation method thereof | |
| CN102861287B (en) | Chinese medicinal composition for treating damp-heat invasion blood stasis diabetic foot and preparation method thereof | |
| CN104127813A (en) | Traditional Chinese medicinal composition for curing qi-blood deficiency type bedsore and preparation method thereof | |
| CN100350934C (en) | Baidianxiao treaditional Chinese medicine for treating vitiligo and preparation method thereof | |
| CN111110759A (en) | Water-eliminating ointment for treating cancerous ascites and preparation method thereof | |
| CN100434109C (en) | Medicine ointment for treating burns and scalds and its prepn | |
| CN101342331B (en) | Traditional Chinese medicine for treating pulmonitis and upper respiratory tract infection | |
| CN108355042A (en) | A kind of anti-inflammatory analgetic ointment and preparation method thereof | |
| CN101953951B (en) | Hand and feed health-care and beautifying liquid and preparation method thereof | |
| CN105997737A (en) | Lvtou purifying herbal patch | |
| CN105617268A (en) | Medicine for treating scale keratinization type beriberi | |
| CN104474103A (en) | Natural plant hypoglycemic agent and preparation method thereof | |
| CN1141105C (en) | Cancer curing medicine liquid | |
| CN1057449C (en) | Medicine for tinea | |
| CN1068223C (en) | Pill for treating hepatopathy | |
| CN107496567A (en) | A kind of Chinese medicine preparation for treating diabetic foot and preparation method thereof | |
| CN107753670A (en) | A kind of traditional Chinese medicinal ointment for treating burn and scald | |
| CN106236900A (en) | A kind of for compound medicine treating burn and preparation method thereof | |
| TWI260226B (en) | Complex prescription of Chinese medicine for the treatment of extensive cancer | |
| CN1088801A (en) | Chinese patent medicine Jinguanpian tablets and the method for making thereof of treatment insensitive impediment, particularly RA and AS | |
| CN104069056A (en) | Skin-soothing itching-relieving lotion | |
| CN104645105B (en) | Treat drug and the preparation of the hematuria caused by movement | |
| CN100336556C (en) | Chinese medicine for treating nephritis, vrinemia and its manufacturing method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |